Background: There is insufficient data to reliably assess the benefit of bronchodilators in ventilated premature neonates.
Objectives: To compare the efficacy/tolerance of inhaled ipratropium bromide (IB) vs. terbutaline (T) and to describe factors associated with their efficacy.